Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Laboratory Reagents for NAMRU-6’s Virology & Emerging Infections Department

by Global Biodefense Staff
April 28, 2017
NAMRU-6 PERU

The Naval Medical Research Unit 6 (NAMRU-6) is seeking to purchase laboratory reagents to be used for molecular diagnosis of Influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus and Zika virus in the Virology & Emerging Infections Department.

NAMRU-6 is a biomedical research laboratory of the US Navy located in Lima, Peru. Its mission is to identify infectious diseases threats of military and public health importance and to develop and evaluate interventions and products to mitigate those threats.

The current requirement specifically supports NAMRU-6 assays that have been validated using the TaqMan 7500/7500 Fast Real time PCR system and therefore, compatibility of the consumables is a requirement.

The RT-PCR assays have been developed independently for each of NAMRU-6’s Standard Operating Procedures (SOP) and involve a significant effort by laboratory technicians, and supervisors for final approval. Changes to reagents would a full revalidation process, which would delay processing and the timely diagnosis of public health relevant pathogens.

Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work.

Further details are available via Solicitation Number: VEI170003. Capability statements are due by 12:00 PM Local Time (Peru), 02 May 2017.

Tags: AdenovirusEnterovirus D68InfluenzaRFIZika

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC